Corcept Therapeutics Inc
CORT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $4.12M | $1.38M | — | — |
| Net Income | -$11.12M | -$11.12M | -$9.94M | — |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| -$0.11 |
| -$0.11 |
| -$0.12 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.